Preferences help
enabled [disable] Abstract
Number of results
2016 | 63 | 3 | 571-575
Article title

Comparative effects of selected plant polyphenols, gallic acid and epigallocatechin gallate, on matrix metalloproteinases activity in multidrug resistant MCF7/DOX breast cancer cells

Title variants
Languages of publication
The aim of the study was to investigate the effect of selected polyphenols: gallic acid (GA) and epigallocatechin gallate (EGCG) on matrix metalloproteinase (MMP-2 and MMP-9) activity in multidrug resistant (MDR) human breast adenocarcinoma cells: MCF7/DOX cells and obtained recently in our laboratory MCF7/DOX500 cells by the permanent selection of MCF7/DOX cells with 500 nM doxorubicin (DOX). The activity of MMP-2 and MMP-9 and the effect of studied polyphenols on these matrix proteases were examined by gelatin zymography assays. We have found that the activity of MMP-2 and MMP-9 significantly increased in resistant MCF7/DOX and MCF7/DOX500 cells whereas they were not detected in sensitive MCF7 cells. It was also observed that GA (30, 60, 100 and 120 µM) and EGCG (5, 10 and 20 µM) caused a comparable concentration-dependent inhibition of MMP-2 and MMP-9 activity in MCF7/DOX and MCF7/DOX500 cells. Control experiments confirmed that examined compounds in these ranges of concentration did not affect the cell growth of MCF7/DOX and MCF7/DOX500 sublines (80-100% of control cell growth was observed in the presence of studied polyphenols).
Physical description
  • Department of Biochemistryi and Molecular Biology and Biotechnology Center, Faculty of Biology, University of Szczecin, Szczecin, Poland
  • Department of Biochemistryi and Molecular Biology and Biotechnology Center, Faculty of Biology, University of Szczecin, Szczecin, Poland
  • Afzal M, Safer AM, Menon M (2015) Green tea polyphenols and their potential role in health and disease. Inflammopharmacology 23: 151-161.
  • Baguley BC (2010) Multiple drug resistance mechanisms in cancer. Mol Biotechnol 46: 308-316. doi: 10.1007/s10787-015-0236-1.
  • Borst P, Jonkers J, Rottenberg S (2007) What makes tumors multidrug resistant? Cell Cycle 6: 2782-2787. doi: 10.1007/s12033-010-9321-2.
  • Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM (2010) Molecular interactions in cancer cell metastasis. Acta Histochem 112: 3-25. doi: 10.4161/cc.6.22.4936.
  • Chabottaux V, Noel A (2007) Breast cancer progression: insights into multifaceted matrix metalloproteinases. Clin Exp Metastasis 24: 647-656. doi: 10.1016/j.acthis.2008.11.022.
  • Chen PN, Chu SC, Kuo WH, Chou MY, Lin JK, Hsieh YS (2011) Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells. J Agric Food Chem 59: 3836-3844. doi: 10.1007/s10585-007-9113-7.
  • Chen YJ, Chang LS (2012) Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/Abl. Mol Nutr Food Res 56: 1398-1412. doi: 10.1021/jf1049408.
  • Christensen J, Shastri VP (2015) Matrix-metalloproteinase-9 is cleaved and activated by cathepsin K. BMC Res Notes 8: 322. doi: 10.1002/mnfr.201200167.
  • Colone M, Calcabrini A, Toccacieli L, Bozzuto G, Stringaro A, Gentile M, Cianfriglia M, Ciervo A, Caraglia M, Budillon A, Meo G, Arancia G, Molinari A (2008) The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? J Invest Dermatol 128: 957-971. doi: 10.1186/s13104-015-1284-8.
  • Farabegoli F, Papi A, Orlandi M (2011) (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Biosci Rep 31: 99-108. doi: 10.1038/sj.jid.5701082.
  • Ho HH, Chang CS, Ho WC, Liao SY, Wu CH, Wang CJ (2010) Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-kappaB activity and downregulation of PI3K/AKT/small GTPase signals. Food Chem Toxicol 48: 2508-2516. doi: 10.1042/BSR20090143.
  • Işeri OD, Kars MD, Arpaci F, Gündüz U (2010) Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins. Cancer Chemother Pharmacol 65: 447-455. doi: 10.1016/j.fct.2010.06.024.
  • Kampa M, Nifli AP, Notas G, Castanas E (2007) Polyphenols and cancer cell growth. Rev Physiol Biochem Pharmacol 159: 79-113. doi: 10.1007/s00280-009-1048-z.
  • Karroum A, Mirshahi P, Benabbou N, Faussat AM, Soria J, Therwath A, Mirshahi M, Hatmi M (2010) Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways. Cancer Lett 295: 242-251. doi: 10.1007/112_2006_0702.
  • Kaur M, Velmurugan B, Rajamanickam S, Agarwal R, Agarwal C (2009) Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice. Pharm Res 26: 2133-2140. doi: 10.1016/j.canlet.2010.03.007.
  • Lecumberri E, Dupertuis YM, Miralbell R, Pichard C (2013) Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin Nutr 32: 894-903. doi: 10.1007/s11095-009-9926-y.
  • Liang Y, O'Driscoll L, McDonnell S, Doolan P, Oglesby I, Duffy K, O'Connor R, Clynes M (2004) Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung canciroma cell line after pulse selection with anticancer drugs. Int J Cancer 111: 484-493. doi: 10.1016/j.clnu.2013.03.008.
  • Li QQ, Wang WJ, Xu JD, Cao XX, Chen Q, Yang JM, Xu ZD (2007) Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells. Cancer Sci 98: 1767-1774. doi: 10.1002/ijc.20230.
  • Liu KC, Huang AC, Wu PP, Lin HY, Chueh FS, Yang JS, Lu CC, Chiang JH, Meng M, Chung JG (2011) Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways. Oncol Rep 26: 177-184. doi: 10.1111/j.1349-7006.2007.00593.x.
  • Lo C, Lai TY, Yang JS, Yang JH, Ma YS, Weng SW, Lin HY, Chen HY, Lin JG, Chung JG (2011) Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras. Melanoma Res 21: 267-273. doi: 10.3892/or.2011.1264.
  • Lu LS, Chen L, Ding WX, Li K, Wu JJ (2012) Elevated expression of both MDR1 and MMP-2 genes in metastasized lymph node of invasive ductal breast cancer. Eur Rev Med Pharmacol Sci 16: 2037-2043. doi: 10.1097/CMR.0b013e3283414444.
  • Lu Y, Jiang F, Jiang H, Wu K, Zheng X, Cai Y, Katakowski M, Chopp M, To SS (2010) Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells. Eur J Pharmacol 641: 102-107.
  • Molinari A, Stringaro A, Gentile M, Colone M, Toccacieli L, Arancia G (2005) Invasive properties of multidrug resistant human melanoma cells. Ital J Anat Embryol 110 (2 Suppl 1): 135-141. doi: 10.1016/j.ejphar.2010.05.043.
  • Osmak M, Niksíc D, Brozović A, Ristov AA, Vrhovec I, Skrk J (1999) Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasis. Anticancer Res 19: 3193-3197.
  • Park AM, Dong Z (2003) Signal transduction pathways: targets for green and black tea polyphenols. J Biochem Mol Biol 36: 66-77. doi: 10.5483/BMBRep.2003.36.1.066.
  • Raguz S, Tamburo De Bella M, Tripuraneni G, Slade MJ, Higgins CF, Coombes RC, Yagüe E (2004) Activation of the MDR1 upstream promoter in breast carcinoma as a surrogate for metastatic invasion. Clin Cancer Res 10: 2776-2783. doi: 10.1158/1078-0432.CCR-03-0517.
  • Raina K, Rajamanickam S, Deep G, Singh M, Agarwal R, Agarwal C (2008) Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice. Mol Cancer Ther 7: 1258-1267. doi: 10.1158/1535-7163.MCT-07-2220.
  • Ramos S (2008) Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 52: 507-526. doi: 10.1002/mnfr.200700326.
  • Roomi MW, Monterrey JC, Kalinovsky T, Rath M, Niedzwiecki A (2010) Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines. Oncol Rep 24: 747-757.
  • Sen T, Chatterjee A (2011) Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process. Eur J Nutr 50: 465-478. doi: 10.3892/or_00000917.
  • Sen T, Dutta A, Chatterjee A (2010) Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. Anticancer Drugs 21: 632-644. doi: 10.1007/s00394-010-0158-z.
  • Sen T, Moulik S, Dutta A, Choudhury PR, Banerji A, Das S, Roy M, Chatterjee A (2009) Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci 84: 194-204. doi: 10.1097/CAD.0b013e32833a4385.
  • Sharom FJ (2008) ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9: 105-127. doi: 10.1016/j.lfs.2008.11.018.
  • Smith NZ (2012) Treating metastatic breast cancer with systemic chemotherapies: current trends and future perspectives. Clin J Oncol Nurs 16: E33-E43. doi: 10.2217/14622416.9.1.105.
  • Sugiura Y, Ma L, Sun B, Shimada H, Laug WE, Seeger RC, DeClerck YA (1999) The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor in metastasis. Cancer Research 59: 1327-1336. doi: 10.1188/12.CJON.E33-E43.
  • Westermarck J, Kähäri VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792.
  • Yang JM, Xu Z, Wu H, Zhu H, Wu X, Hait WN (2003) Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 1: 420-427.
  • Zhang G, Wang Y, Zhang Y, Wan X, Li J, Liu K, Wang F, Liu K, Liu Q, Yang C, Yu P, Huang Y, Wang S, Jiang P, Qu Z, Luan J, Duan H, Zhang L, Hou A, Jin S, Hsieh TC, Wu E (2012) Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Curr Mol Med 12: 163-176. doi: 10.2174/156652412798889063.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.